Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

VanEck Morningstar Wide Moat ET (MOAT)

2026-02-26T14:51:31.246675+00:00

Key Updates

MOAT has advanced 2.33% since the December 31 report to $106.74, extending its post-year-end momentum and establishing a new all-time high. The ETF's YTD performance of 3.07% demonstrates continued strength in quality-focused strategies, though momentum has moderated from the exceptional 12.49% YTD gains recorded at year-end 2025. The most significant development is Morningstar's completion of the $365 million CRSP acquisition, solidifying its position as the leading provider of broad U.S. equity benchmarks with over $4.2 trillion in assets linked across 370+ investment products—a strategic move that enhances the credibility and infrastructure supporting the Wide Moat methodology underlying MOAT's portfolio construction.

Current Trend

MOAT exhibits strong technical momentum with positive returns across all short-term timeframes except the 1-month period (-0.17%). The 6-month gain of 8.51% and YTD advance of 3.07% confirm the fund's positioning within an established uptrend that began in Q4 2024. Recent price action shows consistent strength: +0.58% over 1 day and +0.55% over 5 days, indicating sustained buying pressure. The fund has successfully cleared the $104.31 resistance level from year-end and established new support in the $106-107 range. The 2.33% gain since the last report represents continuation rather than acceleration, suggesting consolidation at elevated levels as the market digests the strong 2025 performance. The minor 1-month pullback appears technical in nature, representing healthy profit-taking within the broader uptrend.

Investment Thesis

The investment thesis for MOAT centers on systematic exposure to companies with sustainable competitive advantages—economic moats—that Morningstar's methodology identifies as capable of generating excess returns over extended periods. The fund's strategy focuses on undervalued wide-moat companies, providing a quality-growth orientation with valuation discipline. Recent portfolio holdings analysis reveals concentration in established market leaders across healthcare (GE HealthCare), retail (Home Depot), and financial services (S&P Global), all possessing durable competitive advantages through scale economies, switching costs, and network effects. The thesis benefits from two structural tailwinds: first, the growing institutional adoption of active ETFs, with assets surging from $52 billion in 2016 to nearly $1.5 trillion in 2025; second, Morningstar's enhanced market position following the CRSP acquisition, which strengthens its indexing capabilities and competitive positioning against legacy providers. The fund's quality-focused approach provides defensive characteristics during market volatility while maintaining participation in long-term equity appreciation.

Thesis Status

The investment thesis remains firmly intact and has been strengthened by recent developments. The Morningstar-CRSP acquisition validates the strategic importance of the indexing business and provides enhanced resources for the research infrastructure supporting the Wide Moat methodology. Portfolio holdings continue to demonstrate the thesis in action: Home Depot's wide economic moat built on scale economies and brand equity, GE HealthCare's top-three global positioning in medical imaging with demographic tailwinds, and S&P Global's data-driven benchmarks generating high-margin recurring revenue. The fund's 3.07% YTD performance, while more modest than 2025's exceptional gains, demonstrates continued effectiveness of the quality-focused approach. The broader trend toward active ETF adoption (64% asset growth in 2025) provides structural support for MOAT's positioning as a systematic active strategy. No material changes to the thesis are warranted based on current evidence.

Key Drivers

The primary catalyst is Morningstar's $365 million CRSP acquisition, completed February 2, 2026, which brings $3 trillion in U.S. equity benchmarks under the Morningstar Indexes umbrella and secures continued partnership with Vanguard for major index funds. This transaction enhances Morningstar's competitive positioning against legacy index providers and strengthens the research infrastructure supporting MOAT's methodology. Portfolio-level drivers include Home Depot's operational excellence initiatives expected to restore operating margins to prepandemic levels despite industry headwinds, GE HealthCare's positioning to capitalize on aging demographics and increased demand for early disease detection, and S&P Global's diversified revenue model following the $44 billion IHS Markit acquisition providing more stable recurring revenue. The structural shift toward active ETF strategies, with 1,200% growth in product count since 2016 and major asset managers launching new offerings, creates favorable market conditions for MOAT's systematic active approach. Enhanced retail trading platform capabilities for ETF access further supports distribution and liquidity.

Technical Analysis

MOAT has established a new all-time high at $106.74, breaking above the $104.31 resistance level from December 31, 2025. The price structure shows a clear uptrend with higher lows and higher highs since Q4 2024. Short-term momentum indicators are positive, with 1-day (+0.58%) and 5-day (+0.55%) gains confirming buying pressure, though the pace has moderated from the exceptional year-end rally. The minor 1-month decline of -0.17% represents a shallow consolidation that has been fully recovered, suggesting strong underlying demand at current levels. Support has been established in the $106-107 zone, with previous resistance at $104.31 now serving as secondary support. The 6-month gain of 8.51% places the fund in the upper quartile of its historical trading range, indicating extended but not overextended conditions. Volume patterns suggest institutional accumulation rather than speculative excess. The technical setup remains constructive, with the fund respecting its uptrend structure while consolidating recent gains. Key resistance levels to monitor are psychological barriers at $110 and $115, while support rests at $104 and $101.60 (November 2025 level).

Bull Case

Bear Case

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.